Regenerative medicine gets a boost … in Russia. Cytori Therapeutics’ Celution(R) 800 System is now approved for various medical uses in Russia including plastic surgery and select soft tissue therapies.
These clinical uses are based on those in the current European CE Mark. The Celution system separates stem cells from fat. By contrast, Cytori’s PureGraft system prepares fat grafts. The Puregraft system is approved by the U.S. FDA.
The Celution(R) system and related products will be sold into Russia exclusively through Cytori’s distribution partner, Human Stem Cells Institute of Moscow.